Clinical trial · Observational
Intrathecal Analgesia Effects on Cancer Patients Discomfort Symptoms
Evaluation of Discomfort Symptoms in Patients With Refractory Cancer Pain and Intrathecal Analgesia Management
NCT04491123CI-TRIAL-00046256IT-ESAScompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Intrathecal analgesia is used in refractory cancer pain because of drug sides effects or intractable pain. The aim of this approach is to improve pain management, and also to improve patient comfort. This study will assess patient discomfort symptoms before and after setting up intrathecal analgesia.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Intrathecal Analgesia | — | UNRESOLVED | — |
| Refractory Cancer Pain | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Number Evaluation of Edmonton symptoms
- timeFrame
- up to 90 days after patient inclusion
- description
- Edmonton symptom assessment system
Secondary outcomes (1)
- measure
- Autonomy assessment score for activities of daily living
- timeFrame
- 1 day
- description
- Autonomy assessment score for activities of daily living
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria: * patients aged 18 and older * obligation of affiliation or beneficiary of a social security scheme * patients with cancer and refractory localized cancer pain because of drug side effects or intractable pain * localized pain in topography accessible to intrathecal analgesia (legs, abdomen and pelvis, pancoast-tobias symdrom) * patient's informed consent for the study * patient able to complete the evaluation questionnaires * estimed vital prognosis more than three month * patient with all conditions for intrathecal anagelsia Exclusion criteria: * patient with intracranial hypertension * refusal of patient to be included in the study * refusal of patient to receive intrathecal analgesia * patient with many refractory pain localizations not accessible to intrathecal analgesia
References
Publications (0)
Data not yet available
No reference posted for this study.